
The Intercept @theintercept
President Joe Biden’s administration “anticipates” that regulators will approve MDMA and psilocybin within the next two years for designated breakthrough therapies for PTSD and depression respectively. https://t.co/DlbkTFv79f — PolitiTweet.org